Catalent (CTLT) PT Raised to $137 at RBC Capital, 'COVID-Related Programs Continue to Drive FY21 Outlook Higher'
Tweet Send to a Friend
RBC Capital analyst Sean Dodge raised the price target on Catalent (NYSE: CTLT) to $137.00 (from $125.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
